Informacja

Drogi użytkowniku, aplikacja do prawidłowego działania wymaga obsługi JavaScript. Proszę włącz obsługę JavaScript w Twojej przeglądarce.

Przeglądasz jako GOŚĆ

Wyszukujesz frazę ""Munier CML"" wg kryterium: Autor


Wyświetlanie 1-13 z 13
Tytuł :
The Role of ZEB2 in Human CD8 T Lymphocytes: Clinical and Cellular Immune Profiling in Mowat-Wilson Syndrome.
Autorzy :
Frith K; Sydney Children's Hospital, Randwick, NSW 2031, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW 2052, Australia.
Munier CML; The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW 2052, Australia.
Hastings L; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Mowat D; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Wilson M; Department of Clinical Genetics, Children's Hospital at Westmead, Sydney, NSW 2145, Australia.
Seddiki N; INSERM U955 Eq16, Vaccine Research Institute and Université Paris Est Créteil, F-94010 Créteil, France.
Macintosh R; Sydney Children's Hospital, Randwick, NSW 2031, Australia.
Kelleher AD; The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW 2052, Australia.; Centre for Applied Medical Research, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Gray P; Sydney Children's Hospital, Randwick, NSW 2031, Australia.; School of Women's and Children's Health, UNSW Sydney, Sydney, NSW 2052, Australia.
Zaunders JJ; The Kirby Institute for Infection and Immunity in Society, UNSW Sydney, Sydney, NSW 2052, Australia.; Centre for Applied Medical Research, St Vincent's Hospital, Darlinghurst, NSW 2010, Australia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 May 18; Vol. 22 (10). Date of Electronic Publication: 2021 May 18.
Typ publikacji :
Case Reports; Journal Article
MeSH Terms :
CD8-Positive T-Lymphocytes/*immunology
Hirschsprung Disease/*immunology
Intellectual Disability/*immunology
Microcephaly/*immunology
Zinc Finger E-box Binding Homeobox 2/*immunology
Animals ; Case-Control Studies ; Child ; Child, Preschool ; Facies ; Female ; Gene Expression Profiling ; Haploinsufficiency ; Hirschsprung Disease/genetics ; Humans ; Immunity, Cellular ; Immunologic Memory/genetics ; Intellectual Disability/genetics ; Lymphocyte Activation/genetics ; Male ; Mice ; Mice, Knockout ; Microcephaly/genetics ; Mutation ; T-Lymphocyte Subsets/immunology ; Young Adult ; Zinc Finger E-box Binding Homeobox 2/deficiency ; Zinc Finger E-box Binding Homeobox 2/genetics
SCR Disease Name :
Mowat-Wilson syndrome
Czasopismo naukowe
Tytuł :
CD73 Long-Term Memory CD4 T Cells Are Highly Proliferative in Response to Recall Antigens and Are Early Targets in HIV-1 Infection.
Autorzy :
Seddiki N; INSERM U955, Equipe 16, 94000 Créteil, France.; Faculté de médecine, Université Paris-Est Créteil, 94000 Créteil, France.; Vaccine Research Institute (VRI), 94000 Créteil, France.
Zaunders J; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW 2010, Australia.; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Phetsouphanh C; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Brezar V; INSERM U955, Equipe 16, 94000 Créteil, France.
Xu Y; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
McGuire HM; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.; Ramaciotti Facility for Human Systems Biology, The University of Sydney, Sydney, NSW 2006, Australia.; Discipline of Pathology, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Bailey M; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
McBride K; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Hey-Cunningham W; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Munier CML; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Cook L; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Kent S; Department of Microbiology and Immunology, University of Melbourne, Melbourne, VIC 3010, Australia.
Lloyd A; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Cameron B; School of Medical Sciences, University of New South Wales, Sydney, NSW 2052, Australia.
Fazekas de St Groth B; Charles Perkins Centre, The University of Sydney, Sydney, NSW 2006, Australia.; Ramaciotti Facility for Human Systems Biology, The University of Sydney, Sydney, NSW 2006, Australia.; Discipline of Pathology, Faculty of Medicine and Health, The University of Sydney, Sydney, NSW 2006, Australia.
Koelsch K; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Danta M; St Vincent's Clinical School, St Vincent's Hospital and University of New South Wales, Sydney, NSW 2052, Australia.
Hocini H; INSERM U955, Equipe 16, 94000 Créteil, France.
Levy Y; INSERM U955, Equipe 16, 94000 Créteil, France.; Faculté de médecine, Université Paris-Est Créteil, 94000 Créteil, France.; Vaccine Research Institute (VRI), 94000 Créteil, France.; AP-HP, Hôpital H. Mondor-A. Chenevier, Service d'immunologie Clinique et Maladies Infectieuses, 94000 Créteil, France.
Kelleher AD; Kirby Institute, University of New South Wales, Sydney, NSW 2052, Australia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2021 Jan 18; Vol. 22 (2). Date of Electronic Publication: 2021 Jan 18.
Typ publikacji :
Journal Article
MeSH Terms :
Molecular Targeted Therapy*
Antigens, CD/*immunology
Cell Proliferation/*genetics
HIV Infections/*genetics
5'-Nucleotidase/genetics ; 5'-Nucleotidase/immunology ; Antigens, CD/genetics ; Antigens, CD/therapeutic use ; Cell Lineage/genetics ; Cell Lineage/immunology ; HIV Infections/immunology ; HIV Infections/pathology ; HIV Infections/virology ; HIV-1/immunology ; HIV-1/pathogenicity ; Humans ; Interleukin-7 Receptor alpha Subunit/genetics ; Interleukin-7 Receptor alpha Subunit/immunology ; Memory, Long-Term/physiology
Czasopismo naukowe
Tytuł :
Mucosal-associated invariant T (MAIT) cells are activated in the gastrointestinal tissue of patients with combination ipilimumab and nivolumab therapy-related colitis in a pathology distinct from ulcerative colitis.
Autorzy :
Sasson SC; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Zaunders JJ; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
Nahar K; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.
Munier CML; The Kirby Institute, University of New South Wales, Sydney, Australia.
Fairfax BP; Department of Oncology, Churchill Hospital, Oxford, UK.; Department of Oncology, University of Oxford, Oxford, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Olsson-Brown A; The Clatterbridge Cancer Centre NHS Foundation Trust and Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Jolly C; The Clatterbridge Cancer Centre NHS Foundation Trust and Institute of Translational Medicine, University of Liverpool, Liverpool, UK.
Read SA; Westmead Institute of Medical Research, Sydney, Australia.; Western Sydney University, Sydney, Australia.
Ahlenstiel G; Westmead Institute of Medical Research, Sydney, Australia.; Department of Gastroenterology, Blacktown Hospital, Sydney, Australia.
Palendira U; Discipline of Infectious Diseases and Immunology, The University of Sydney, Sydney, Australia.
Scolyer RA; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Department of Tissue Pathology and Diagnostic Oncology, Royal Prince Alfred Hospital, Sydney, Australia.
Carlino MS; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Department of Medical Oncology, Westmead and Blacktown Hospitals, Sydney, Australia.
Payne MJ; Department of Oncology, Churchill Hospital, Oxford, UK.
Cheung VTF; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.
Gupta T; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; MRC Weatherall Institute of Molecular Medicine, University of Oxford, Oxford, UK.
Klenerman P; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Peter Medawar Building of Pathogen Research, University of Oxford, Oxford, UK.
Long GV; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Department of Medical Oncology, Royal North Shore Hospital and Mater Hospitals, Sydney, Australia.
Brain O; Translational Gastroenterology Unit and Oxford Biomedical Research Centre, Nuffield Department of Medicine, University of Oxford, Oxford, UK.; Department of Gastroenterology, John Radcliffe Hospital, Oxford, UK.
Menzies AM; Melanoma Institute Australia and The University of Sydney, Sydney, Australia.; Department of Medical Oncology, Royal North Shore Hospital and Mater Hospitals, Sydney, Australia.
Kelleher AD; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.; The Kirby Institute, University of New South Wales, Sydney, Australia.
Pokaż więcej
Źródło :
Clinical and experimental immunology [Clin Exp Immunol] 2020 Dec; Vol. 202 (3), pp. 335-352. Date of Electronic Publication: 2020 Aug 19.
Typ publikacji :
Clinical Trial; Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD8-Positive T-Lymphocytes*/immunology
CD8-Positive T-Lymphocytes*/pathology
Colitis*/chemically induced
Colitis*/immunology
Colitis*/pathology
Intestinal Mucosa*/immunology
Intestinal Mucosa*/pathology
Mucosal-Associated Invariant T Cells*/immunology
Mucosal-Associated Invariant T Cells*/pathology
T-Lymphocytes, Regulatory*/immunology
T-Lymphocytes, Regulatory*/pathology
Ipilimumab/*adverse effects
Nivolumab/*adverse effects
Adult ; Aged ; Female ; Flow Cytometry ; Humans ; Ipilimumab/administration & dosage ; Male ; Middle Aged ; Nivolumab/administration & dosage
Czasopismo naukowe
Tytuł :
Tfh Cells in Health and Immunity: Potential Targets for Systems Biology Approaches to Vaccination.
Autorzy :
Law H; The Kirby Institute, UNSW Sydney, Sydney 2052, Australia.
Venturi V; The Kirby Institute, UNSW Sydney, Sydney 2052, Australia.
Kelleher A; The Kirby Institute, UNSW Sydney, Sydney 2052, Australia.; St Vincent's Clinical School, UNSW Sydney, Sydney 2052, Australia.
Munier CML; The Kirby Institute, UNSW Sydney, Sydney 2052, Australia.
Pokaż więcej
Źródło :
International journal of molecular sciences [Int J Mol Sci] 2020 Nov 12; Vol. 21 (22). Date of Electronic Publication: 2020 Nov 12.
Typ publikacji :
Journal Article; Review
MeSH Terms :
Systems Biology*
Vaccines*
Germinal Center/*immunology
T Follicular Helper Cells/*immunology
Animals ; B-Lymphocytes/immunology ; Biomarkers/metabolism ; CD4-Positive T-Lymphocytes/immunology ; Cell Differentiation ; Humans ; Immune System ; Lymph Nodes/immunology ; RNA, Small Cytoplasmic/metabolism ; RNA-Seq ; Receptors, Antigen, T-Cell/immunology ; Signal Transduction ; T-Lymphocytes/immunology ; Treatment Outcome ; Vaccination
Czasopismo naukowe
Tytuł :
Evaluation of Commercially Available Viral Transport Medium (VTM) for SARS-CoV-2 Inactivation and Use in Point-of-Care (POC) Testing.
Autorzy :
van Bockel D; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Munier CML; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Turville S; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Badman SG; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Walker G; NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW 2052, Australia.
Stella AO; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Aggarwal A; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Yeang M; NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW 2052, Australia.
Condylios A; NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW 2052, Australia.
Kelleher AD; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Applegate TL; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Vallely A; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Whiley D; NSW State Reference Laboratory for HIV-AIDS/St Vincent's Hospital Sydney, St Vincent's Centre for Applied Medical Research, St Vincent's Hospital Sydney Limited, Darlinghurst, NSW 2010, Australia.; Australia Pathology Queensland, Royal Brisbane and Women's Hospital, Herston, QLD 4006, Australia.
Rawlinson W; NSW Health Pathology, Prince of Wales Hospital, Randwick, NSW 2052, Australia.
Cunningham P; Centre for Clinical Research, The University of Queensland, Royal Brisbane and Women's Hospital Campus, Herston, QLD 4006, Australia.
Kaldor J; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Guy R; Kirby Institute for Infection and Immunity in Society, UNSW Medicine, UNSW Sydney, Kensington, NSW 2052, Australia.
Pokaż więcej
Źródło :
Viruses [Viruses] 2020 Oct 23; Vol. 12 (11). Date of Electronic Publication: 2020 Oct 23.
Typ publikacji :
Evaluation Study; Journal Article; Research Support, N.I.H., Extramural
MeSH Terms :
Point-of-Care Testing*/standards
Specimen Handling*/methods
Specimen Handling*/standards
Virus Inactivation*/drug effects
Betacoronavirus/*isolation & purification
COVID-19 Testing ; Clinical Laboratory Techniques ; Coronavirus Infections/diagnosis ; Culture Media/analysis ; Culture Media/pharmacology ; Humans ; SARS-CoV-2 ; Viral Load/drug effects
Czasopismo naukowe
Tytuł :
Mapping the extent of heterogeneity of human CCR5+ CD4+ T cells in peripheral blood and lymph nodes.
Autorzy :
Zaunders J; Centre for Applied Medical Research, St Vincent's Hospital Sydney, Darlinghurst.
Munier CML; Kirby Institute, UNSW Sydney.
McGuire HM; Ramaciotti Facility for Human Systems Biology.; Charles Perkins Centre.; Faculty of Medicine and Health, Discipline of Pathology, The University of Sydney, Sydney.
Law H; Kirby Institute, UNSW Sydney.
Howe A; Kirby Institute, UNSW Sydney.
Xu Y; Kirby Institute, UNSW Sydney.
de St Groth BF; Ramaciotti Facility for Human Systems Biology.; Charles Perkins Centre.; Faculty of Medicine and Health, Discipline of Pathology, The University of Sydney, Sydney.
Schofield P; Garvan Institute of Medical Research, Sydney.
Christ D; Garvan Institute of Medical Research, Sydney.
Milner B; Medical Imaging Department, St Vincent's Hospital Sydney, Darlinghurst.
Obeid S; Medical Imaging Department, St Vincent's Hospital Sydney, Darlinghurst.
Dyer WB; Australian Red Cross Blood Service, Sydney.; Faculty of Medicine and Health, University of Sydney, Sydney, New South Wales.
Saksena NK; Epigene Australia Pty Ltd, Melbourne, Victoria, Australia.
Kelleher AD; Centre for Applied Medical Research, St Vincent's Hospital Sydney, Darlinghurst.; Kirby Institute, UNSW Sydney.
Pokaż więcej
Źródło :
AIDS (London, England) [AIDS] 2020 May 01; Vol. 34 (6), pp. 833-848.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
CD4-Positive T-Lymphocytes*
Granzymes*
HIV-1/*metabolism
Lymph Nodes/*pathology
Receptors, CCR5/*blood
Biopsy, Fine-Needle ; CD4 Lymphocyte Count ; HIV Infections ; HIV-1/genetics ; Humans ; Lymph Nodes/surgery ; Microarray Analysis ; T-Lymphocyte Subsets
Czasopismo naukowe
Tytuł :
Circulating gluten-specific, but not CMV-specific, CD39 regulatory T cells have an oligoclonal TCR repertoire.
Autorzy :
Cook L; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.; St Vincent's Centre for Applied Medical Research St Vincent's Hospital Sydney NSW Australia.; Present address: Department of Medicine and BC Children's Hospital Research Institute University of British Columbia Vancouver Canada.
Munier CML; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.
Seddiki N; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.; St Vincent's Centre for Applied Medical Research St Vincent's Hospital Sydney NSW Australia.; Present address: INSERM U955 and Université Paris-Est Créteil (UPEC)/Vaccine Research Institute Créteil France.
Hardy MY; Immunology Division Walter and Eliza Hall Institute Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Parkville VIC Australia.
Anderson RP; Immunology Division Walter and Eliza Hall Institute Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Parkville VIC Australia.; ImmusanT, Inc. Cambridge MA USA.
Zaunders J; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.; St Vincent's Centre for Applied Medical Research St Vincent's Hospital Sydney NSW Australia.
Tye-Din JA; Immunology Division Walter and Eliza Hall Institute Parkville VIC Australia.; Department of Medical Biology The University of Melbourne Parkville VIC Australia.; Department of Gastroenterology The Royal Melbourne Hospital Parkville VIC Australia.
Kelleher AD; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.; St Vincent's Centre for Applied Medical Research St Vincent's Hospital Sydney NSW Australia.
van Bockel D; Immunovirology and Pathogenesis Program The Kirby Institute UNSW Australia Sydney NSW Australia.
Pokaż więcej
Źródło :
Clinical & translational immunology [Clin Transl Immunology] 2020 Jan 12; Vol. 9 (1), pp. e1096. Date of Electronic Publication: 2020 Jan 12 (Print Publication: 2020).
Typ publikacji :
Journal Article
Czasopismo naukowe
Tytuł :
Maintenance of Functional CD57+ Cytolytic CD4+ T Cells in HIV+ Elite Controllers.
Autorzy :
Phetsouphanh C; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Aldridge D; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Marchi E; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Munier CML; Department of Medicine, University of New South Wales, Sydney, NSW, Australia.
Meyerowitz J; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Murray L; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Van Vuuren C; Military Hospital, Bloemfontein, South Africa.
Goedhals D; National Health Laboratory Service, Division of Virology, University of the Free State, Bloemfontein, South Africa.
Fidler S; Imperial College London, London, United Kingdom.
Kelleher A; Department of Medicine, University of New South Wales, Sydney, NSW, Australia.
Klenerman P; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Frater J; Peter Medawar Building for Pathogen Research, University of Oxford, Oxford, United Kingdom.
Pokaż więcej
Źródło :
Frontiers in immunology [Front Immunol] 2019 Aug 08; Vol. 10, pp. 1844. Date of Electronic Publication: 2019 Aug 08 (Print Publication: 2019).
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
HIV Long-Term Survivors*
CD4-Positive T-Lymphocytes/*immunology
CD57 Antigens/*analysis
HIV Infections/*immunology
T-Lymphocyte Subsets/*immunology
Viremia/*immunology
Biomarkers ; CD4-Positive T-Lymphocytes/chemistry ; Cytokines/blood ; Cytotoxicity, Immunologic ; Disease Progression ; HIV Infections/blood ; Humans ; Immunologic Memory ; Immunophenotyping ; Lymphocyte Activation ; Superantigens/immunology ; T-Lymphocyte Subsets/chemistry ; Transcriptome ; Viral Load ; Viremia/blood
Czasopismo naukowe
Tytuł :
Possible clearance of transfusion-acquired nef /LTR-deleted attenuated HIV-1 infection by an elite controller with CCR5 Δ32 heterozygous and HLA-B57 genotype.
Autorzy :
Zaunders J; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Dyer WB; Australian Red Cross Blood Service, Sydney, NSW, Australia.; Faculty of Medicine and Health, University of Sydney, NSW, Australia.
Churchill M; School of Health and Biomedical Sciences, College of Science, Engineering and Health, RMIT University, Bundoora, VIC, Australia.
Munier CML; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Cunningham PH; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.
Suzuki K; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.
McBride K; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Hey-Nguyen W; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Koelsch K; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Wang B; Ingham Institute, Liverpool, NSW, Australia.
Hiener B; Centre for Virus Research, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
Palmer S; Centre for Virus Research, Westmead Institute for Medical Research, University of Sydney, Sydney, NSW, Australia.
Gorry PR; School of Health and Biomedical Sciences, College of Science, Engineering and Health, RMIT University, Bundoora, VIC, Australia.
Bailey M; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Xu Y; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Danta M; Department of Gastroenterology and Hepatology, St Vincent's Hospital, Sydney, NSW, Australia.
Seddiki N; Vaccine Research Institute, Faculté de Médecine, Université Paris Est Créteil, Créteil, France.
Cooper DA; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Saksena NK; IGO Neurodegenerative Disease Section, Sydney, NSW, Australia.; China National Gene Bank, Beijing Institute of Genomics, Shenzhen, China.
Sullivan JS; Australian Red Cross Blood Service, Sydney, NSW, Australia.; Central Clinical School, University of Sydney, NSW, Australia.
Riminton S; Department of Clinical Immunology, Concord Repatriation General Hospital, Sydney, NSW, Australia.
Learmont J; Australian Red Cross Blood Service, Sydney, NSW, Australia.
Kelleher AD; Centre for Applied Medical Research, St Vincent's Hospital, Sydney, NSW, Australia.; Kirby Institute, University of New South Wales, Sydney, NSW, Australia.
Pokaż więcej
Źródło :
Journal of virus eradication [J Virus Erad] 2019 Apr 01; Vol. 5 (2), pp. 73-83. Date of Electronic Publication: 2019 Apr 01.
Typ publikacji :
Editorial
Opinia redakcyjna
Tytuł :
Memory B cells are reactivated in subcapsular proliferative foci of lymph nodes.
Autorzy :
Moran I; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Nguyen A; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Khoo WH; Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; School of Biotechnology and Biomolecular Sciences, Faculty of Science, UNSW, Sydney, NSW, 2052, Australia.
Butt D; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; Biologics Research and Development, Teva Pharmaceuticals, Macquarie Park, NSW, 2113, Australia.
Bourne K; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
Young C; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
Hermes JR; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.
Biro M; EMBL Australia, Single Molecule Science Node, School of Medical Sciences, UNSW, Sydney, NSW, 2052, Australia.
Gracie G; Department of Anatomical Pathology, St Vincent's Hospital, Sydney, NSW, 2010, Australia.
Ma CS; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Munier CML; The Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, NSW, 2052, Australia.
Luciani F; The Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, NSW, 2052, Australia.; School of Medical Sciences, Faculty of Medicine, UNSW, Sydney, NSW, 2052, Australia.
Zaunders J; The Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, NSW, 2052, Australia.; St Vincent's Hospital Sydney Centre for Applied Medical Research, Sydney, Australia.
Parker A; Department of Anatomical Pathology, St Vincent's Hospital, Sydney, NSW, 2010, Australia.
Kelleher AD; The Kirby Institute for Infection and Immunity in Society, UNSW, Sydney, NSW, 2052, Australia.; St Vincent's Hospital Sydney Centre for Applied Medical Research, Sydney, Australia.
Tangye SG; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Croucher PI; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.; Division of Bone Biology, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; School of Biotechnology and Biomolecular Sciences, Faculty of Science, UNSW, Sydney, NSW, 2052, Australia.
Brink R; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia.; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia.
Read MN; School of Life and Environmental Sciences and the Charles Perkins Centre, University of Sydney, Sydney, NSW, 2052, Australia.
Phan TG; Immunology Division, Garvan Institute of Medical Research, Sydney, NSW, 2010, Australia. .; St Vincent's Clinical School, Faculty of Medicine, UNSW, Sydney, NSW, 2010, Australia. .
Pokaż więcej
Źródło :
Nature communications [Nat Commun] 2018 Aug 22; Vol. 9 (1), pp. 3372. Date of Electronic Publication: 2018 Aug 22.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
B-Lymphocytes/*metabolism
Lymph Nodes/*metabolism
Animals ; B-Lymphocytes/immunology ; CD4-Positive T-Lymphocytes/metabolism ; Cell Movement/drug effects ; Cells, Cultured ; Flow Cytometry ; Humans ; Lymph Nodes/immunology ; Mice ; Mice, Inbred C57BL ; Models, Theoretical ; Pyrazoles/pharmacology ; Pyrimidines/pharmacology ; Tamoxifen/pharmacology
Czasopismo naukowe
Tytuł :
Circulating gluten-specific FOXP3 regulatory T cells have impaired suppressive function in patients with celiac disease.
Autorzy :
Cook L; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia. Electronic address: .
Munier CML; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia.
Seddiki N; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
van Bockel D; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia.
Ontiveros N; Immunology Division, Walter and Eliza Hall Institute, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia.
Hardy MY; Immunology Division, Walter and Eliza Hall Institute, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia.
Gillies JK; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Levings MK; Department of Surgery, University of British Columbia, Vancouver, British Columbia, Canada.
Reid HH; Infection and Immunity Program, The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia.
Petersen J; Infection and Immunity Program, The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia.
Rossjohn J; Infection and Immunity Program, The Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, Australia; Australian Research Council Centre of Excellence in Advanced Molecular Imaging, Monash University, Clayton, Australia; Institute of Infection and Immunity, Cardiff University School of Medicine, Heath Park, Cardiff, United Kingdom.
Anderson RP; Immunology Division, Walter and Eliza Hall Institute, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia; ImmusanT, Cambridge, Mass.
Zaunders JJ; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
Tye-Din JA; Immunology Division, Walter and Eliza Hall Institute, Parkville, Australia; Department of Medical Biology, University of Melbourne, Parkville, Australia; Department of Gastroenterology, Royal Melbourne Hospital, Parkville, Australia.
Kelleher AD; Immunovirology and Pathogenesis Program, The Kirby Institute, UNSW Sydney, Sydney, Australia; St Vincent's Centre for Applied Medical Research, St Vincent's Hospital, Sydney, Australia.
Pokaż więcej
Źródło :
The Journal of allergy and clinical immunology [J Allergy Clin Immunol] 2017 Dec; Vol. 140 (6), pp. 1592-1603.e8. Date of Electronic Publication: 2017 Mar 08.
Typ publikacji :
Journal Article
MeSH Terms :
Celiac Disease/*immunology
Glutens/*immunology
T-Lymphocytes, Regulatory/*immunology
Adult ; Antigens, CD/metabolism ; Apyrase/metabolism ; Cells, Cultured ; Enzyme-Linked Immunospot Assay ; Female ; Forkhead Transcription Factors/metabolism ; HLA-DQ Antigens/genetics ; HLA-DQ Antigens/metabolism ; Humans ; Immunosuppression ; Interferon-gamma/metabolism ; Lymphocyte Count ; Male ; Polymorphism, Single Nucleotide ; T-Cell Antigen Receptor Specificity/immunology
Czasopismo naukowe
Tytuł :
The primary immune response to Vaccinia virus vaccination includes cells with a distinct cytotoxic effector CD4 T-cell phenotype.
Autorzy :
Munier CML; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia. Electronic address: .
van Bockel D; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia.
Bailey M; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia.
Ip S; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia.
Xu Y; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia.
Alcantara S; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC, Australia.
Liu SM; The Garvan Institute, Sydney, NSW, Australia.
Denyer G; School of Molecular Bioscience, Faculty of Science, The University of Sydney, NSW, Australia.
Kaplan W; The Garvan Institute, Sydney, NSW, Australia.
Suzuki K; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
Croft N; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Purcell A; Infection and Immunity Program, Department of Biochemistry and Molecular Biology, Biomedicine Discovery Institute, Monash University, Clayton, VIC, Australia.
Tscharke D; John Curtin School of Medical Research, The Australian National University, Canberra, ACT, Australia.
Cooper DA; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
Kent SJ; Department of Microbiology and Immunology, Peter Doherty Institute, University of Melbourne, Melbourne, VIC, Australia; Melbourne Sexual Health Centre and Department of Infectious Diseases, Alfred Health, Central Clinical School, Monash University Melbourne, VIC, Australia; ARC Centre of Excellence in Convergent Bio-Nano Science and Technology, University of Melbourne, Parkville, VIC, Australia.
Zaunders JJ; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
Kelleher AD; The Kirby Institute for infection and immunity in society, UNSW Australia, Sydney, NSW, Australia; St Vincent's Hospital, Sydney, NSW, Australia.
Pokaż więcej
Corporate Authors :
PHIIDO Study group
Źródło :
Vaccine [Vaccine] 2016 Oct 17; Vol. 34 (44), pp. 5251-5261. Date of Electronic Publication: 2016 Sep 14.
Typ publikacji :
Journal Article; Research Support, Non-U.S. Gov't
MeSH Terms :
Cytotoxicity, Immunologic*
Lymphocyte Activation*
CD4-Positive T-Lymphocytes/*immunology
T-Lymphocytes, Cytotoxic/*immunology
Vaccinia virus/*immunology
Viral Vaccines/*immunology
ADP-ribosyl Cyclase 1/genetics ; CD8-Positive T-Lymphocytes/immunology ; Cytokines/genetics ; Granzymes/genetics ; HIV Infections/immunology ; Humans ; Leukocyte Common Antigens/genetics ; Perforin/genetics ; Phenotype ; Tissue Array Analysis ; Up-Regulation ; Viral Vaccines/administration & dosage
Czasopismo naukowe
    Wyświetlanie 1-13 z 13

    Ta witryna wykorzystuje pliki cookies do przechowywania informacji na Twoim komputerze. Pliki cookies stosujemy w celu świadczenia usług na najwyższym poziomie, w tym w sposób dostosowany do indywidualnych potrzeb. Korzystanie z witryny bez zmiany ustawień dotyczących cookies oznacza, że będą one zamieszczane w Twoim komputerze. W każdym momencie możesz dokonać zmiany ustawień dotyczących cookies